GL1X · GenesisL1 explorer

Research workbench

Model of closed pentamer of the haliangium ochraceum encapsulin from symmetry expansion of icosahedral single particle reconstruction

Analyse Model of closed pentamer of the haliangium ochraceum encapsulin from symmetry… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7OE2
Type
protein
Length
1,375 residues
Chains
10
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
LINOCIN_M18 bacteriocin protein; Haliangium ochraceum encapsulated ferritin localisation…
UniProt
D0LZ74, D0LZ73
Pockets
12 · best druggability 0.65

Structure

electron microscopy · 2 distinct chains · 36% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, ELINOCIN_M18 bacteriocin proteinprotein26637% helix, 30% strandD0LZ74
1, 2, 3, 4, 5Haliangium ochraceum encapsulated ferritin localisation sequenceprotein90% helix, 0% strandD0LZ73

Pockets

12 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14350.650.7851empty
24330.640.7850empty
34130.640.7847empty
43990.640.7848empty
54170.630.7750empty

Interfaces

10 interfaces between chains.

  • A–B · 983 Ų buried · 11 hydrogen bonds · protein-protein
  • B–C · 982 Ų buried · 9 hydrogen bonds · protein-protein
  • A–E · 982 Ų buried · 12 hydrogen bonds · protein-protein
  • C–D · 980 Ų buried · 10 hydrogen bonds · protein-protein
  • D–E · 974 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 7OE2 · Model of closed pentamer of the Haliangium ochraceum encapsulin from symmetry expansion… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.